InvestorsHub Logo

BTH

Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: vidpok45 post# 27874

Monday, 03/25/2013 9:00:50 PM

Monday, March 25, 2013 9:00:50 PM

Post# of 80490
You have a tremendous amount of IF in there.

It is really way too early to say '113 is a better drug since the data thus far been small. And, what IF '113 has no effect in EGFR patients, or it cannot be dosed high enough to get a good thera-window?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.